Webinar: Superzyklus Raumfahrt: Mit diesen 10 Aktien können wir vom Jahrhundert-Trend profitieren!

Abiomed Aktie

Watchlist ABMD WKN 873886 ISIN US0036541003

Aktuelle Nachrichten zu Abiomed

  • ‹
  • 1
  • ›

Aktuelle Nachrichten anderer Redaktionen zu Abiomed

www.fool.com

Johnson & Johnson Tops Q2 Estimates

Key PointsAdjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year.Revenue rose 5.8% year over year to $23.7 billion, exceeding estimates by $889 million.Full-year 2025 sales and adjusted earnings guidance were both raised after notable pipeline and product progress.These 10 stocks could mint the next wave of millionaires › Johnson & Johnson (NYSE:JNJ), a global healthcare leader best known for its pharmaceutical, MedTech, and medical device portfolio, reported earni...

www.fool.com

Johnson & Johnson (JNJ) Q2 2025 Earnings Call Transcript

Image source: The Motley Fool. DATEWednesday, July 16, 2025 at 8:30 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Joaquin DuatoChief Financial Officer — Joe WolkChief Financial Officer (transition/introduction) — Darren SnellgroveExecutive Vice President, Worldwide Chairman, Innovative Medicine — Jennifer TaubertExecutive Vice President, Innovative Medicine, Research and Development — John ReedExecutive Vice President, Worldwide Chairman, MedTech — Tim SchmidNeed a quote fro...

www.fool.com

Andrew Hill Dumps 38,000 Johnson & Johnson Shares in Q2 2025 Exit

Key PointsThe investment advisor sold 38,037 shares for a total of $6.31 million in Q2 2025.Move removes JNJ from portfolio, freeing capital for other top holdings.As much as 5.1% of Andrew Hills assets under management (AUM) were reallocated by the end of the second quarter.These 10 stocks could mint the next wave of millionaires › On July 11, 2025, Andrew Hill Investment Advisors, Inc. disclosed it sold out its entire Johnson & Johnson (NYSE:JNJ) position, totaling $6.31 million in trades.Wha...

www.fool.com

Worried About the Economy? 2 No-Brainer Buys to Shield Your Portfolio.

The Nasdaq Composite (NASDAQINDEX: ^IXIC) and the S&P 500 (SNPINDEX: ^GSPC) sank, shifting in and out of correction territory in the first quarter of the year for one big reason: investors have been worried about the economy. President Donald Trump is putting tariffs on imports, and economists predict this could lead to higher inflation and a slowdown in growth. Some have even mentioned the idea of a recession. These are words investors dont like to hear -- and you may even wonder if you should...

www.fool.com

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

When most of us think of investing in stocks, we think of the potential gains -- or unfortunately, in some cases, losses -- that might follow. A particular stock will rise or fall, and well benefit or lose. But, fortunately, a particular type of stock could make you a winner year after year, regardless of its performance or the performance of the stock market as a whole. Im talking about the dividend stock. These players offer you passive income, something that will limit your losses in diffic...

www.globenewswire.com

Global Pharmaceutical Logistics Market Size To Worth USD 191.18 Billion By 2033 | CAGR Of 7.64%

The Global Pharmaceutical Logistics Market Size was Valued at USD 91.60 Billion in 2023 and the Worldwide Pharmaceutical Logistics Market Size is Expected to Reach USD 191.18 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies covered:DHL, Kueche + Nagel, FedEx, United Parcel Service of America, Inc., DB Schenker, LifeConEx, Marken, VersaCold Logistics Services, Ceva Logistics, Yusen Logistics, Tiong Nam, Abiomed, AtriCure, World Courier, and o...

www.globenewswire.com

Global Cardiac Prosthetic Devices Market Size To Exceed USD 14.4 Billion By 2033 | CAGR Of 8.11%

The Global Cardiac Prosthetic Devices Market Size was Valued at USD 6.6 Billion in 2023 and the Worldwide Cardiac Prosthetic Devices Market Size is Expected to Reach USD 14.4 Billion by 2033, according to a research report published by Spherical Insights & Consulting. Companies Covered: Abbott Laboratories, Edwards Lifesciences Corporation, Medtronics Plc., Boston Scientific Corporation, LivaNova, Biotronik, Siemens Healthcare GmbH, Lepu Medical Technology Co. Ltd., Meril Lifesciences Pvt. Ltd....

www.globenewswire.com

Global Recombinant Vaccine Market Size To Exceed USD 24.9 Billion By 2032 | CAGR of 11.75%

The Global Recombinant Vaccine Market Size was Valued at USD 8.2 Billion in 2023 and the Worldwide Recombinant Vaccine Market Size is Expected to Reach USD 24.9 Billion By 2033, according to a research report published by Spherical Insights & Consulting. Companies Covered: AstraZeneca Plc., Dynavax Technologies Corporation, Johnson & Johnson, Merck & Co. Inc., Novovax, Inc., Sanofi S.A., Serum Institute of India Pvt. Ltd., Abiomed, Emergent Bio Solutions, Inc., GlaxoSmithKline, Johnson & Johnson...